World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
64
Citations
21229
World Ranking
2568
National Ranking
1035

Overview

Peter Halfmann is affiliated with the University of Wisconsin-Madison in the United States. Their research primarily focuses on infectious diseases within the broader field of medicine, with significant contributions in epidemiology, molecular biology, animal science and zoology, as well as immunology. Their extensive body of work highlights a concentrated investigation into viral infections, particularly SARS-CoV-2 and COVID-19.

The main topics of Peter Halfmann's research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Viral gastroenteritis research and epidemiology
  • Animal Virus Infections Studies
  • Influenza Virus Research Studies
  • Viral Infections and Outbreaks Research

They have published extensively in high-impact journals, with frequent contributions to venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature
  • SSRN Electronic Journal
  • Nature Communications
  • New England Journal of Medicine

Peter Halfmann's recent notable papers include:

  • "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift," 2021, Nature
  • "Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development," 2020, Proceedings of the National Academy of Sciences
  • "SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo," 2020, Science
  • "An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies," 2022, Nature Medicine
  • "SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters," 2022, Nature

Collaboration plays an important role in their research activities. Their frequent co-authors include:

  • Yoshihiro Kawaoka
  • Makoto Kuroda
  • Michael Diamond
  • Seiya Yamayoshi
  • Tadashi Maemura

Best Publications

  • Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses

    Masato Hatta;Peng Gao;Peter Halfmann;Yoshihiro Kawaoka;Yoshihiro Kawaoka

  • Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

    Unknown

  • Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

    Darwyn Kobasa;Steven M. Jones;Steven M. Jones;Kyoko Shinya;John C. Kash

  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

    Unknown

  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

    Unknown

  • Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.

    Masaki Imai;Kiyoko Iwatsuki-Horimoto;Masato Hatta;Samantha Loeber

  • SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

    Yixuan J. Hou;Shiho Chiba;Peter Halfmann;Camille Ehre

  • Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

    Darwyn Kobasa;Ayato Takada;Kyoko Shinya;Kyoko Shinya;Masato Hatta

  • Transmission of SARS-CoV-2 in Domestic Cats.

    Peter J. Halfmann;Masato Hatta;Shiho Chiba;Tadashi Maemura

  • Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner

    Asuka Nanbo;Masaki Imai;Shinji Watanabe;Takeshi Noda

  • Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

    Unknown

  • Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

    Unknown

  • Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB

    Unknown

  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

    Unknown

  • Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters

    Unknown

  • Defining the risk of SARS-CoV-2 variants on immune protection

    Unknown

  • Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle

    Zachary A. Bornholdt;Takeshi Noda;Dafna M. Abelson;Peter Halfmann

  • Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

    Unknown

  • Pathogenicity and transmissibility of bovine H5N1 influenza virus

    Unknown

  • A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.

    Bronwyn M. Gunn;Wen Han Yu;Marcus M. Karim;Jennifer M. Brannan

  • Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection

    Erica Ollmann Saphire;Sharon L. Schendel;Marnie L. Fusco;Karthik Gangavarapu

  • The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells

    Asuka Nanbo;Shinji Watanabe;Peter Halfmann;Yoshihiro Kawaoka

  • Generation of biologically contained Ebola viruses

    Peter Halfmann;Jin Hyun Kim;Hideki Ebihara;Takeshi Noda

  • The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

    Eve Isabelle Pécheur;Viktoriya Borisevich;Peter Halfmann;John D. Morrey

  • Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.

    Carl W. Davis;Katherine J.L. Jackson;Katherine J.L. Jackson;Anita K. McElroy;Anita K. McElroy;Anita K. McElroy;Peter Halfmann

  • Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus

    Andrew S. Taft;Makoto Ozawa;Adam Fitch;Jay V. Depasse

  • Ebola Virus (EBOV) VP24 Inhibits Transcription and Replication of the EBOV Genome

    Shinji Watanabe;Takeshi Noda;Peter Halfmann;Luke Jasenosky

  • A shared structural solution for neutralizing ebolaviruses

    João M Dias;Ana I Kuehne;Dafna M Abelson;Shridhar Bale

  • Characterization of a Human H5N1 Influenza A Virus Isolated in 2003

    Kyoko Shinya;Masato Hatta;Shinya Yamada;Ayato Takada

  • Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.

    Haley L. Dugan;Christopher T. Stamper;Lei Li;Siriruk Changrob

  • The Cytoprotective Enzyme Heme Oxygenase-1 Suppresses Ebola virus Replication

    Lindsay Hill-Batorski;Peter Halfmann;Gabriele Neumann;Yoshihiro Kawaoka;Yoshihiro Kawaoka

Frequent Co-Authors

Yoshihiro Kawaoka
Yoshihiro Kawaoka University of Tokyo
Gabriele Neumann
Gabriele Neumann University of Wisconsin–Madison
Masato Hatta
Masato Hatta University of Wisconsin–Madison
Erica Ollmann Saphire
Erica Ollmann Saphire La Jolla Institute For Allergy & Immunology
Takeshi Noda
Takeshi Noda Kyoto University
Heinz Feldmann
Heinz Feldmann National Institutes of Health
David H. O’Connor
David H. O’Connor University of Wisconsin–Madison
Florian Krammer
Florian Krammer Icahn School of Medicine at Mount Sinai
Shinji Watanabe
Shinji Watanabe National Institutes of Health
Andrzej Joachimiak
Andrzej Joachimiak Argonne National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of related online degrees and career paths in healthcare and life sciences. For students looking at alternative routes, it's encouraging to know that there are degrees felons can get, ensuring education opportunities remain accessible to many.

A popular healthcare role related to microbiology is the Functional Medicine Nurse Practitioner. To pursue this path, understanding how to become a functional medicine nurse practitioner is essential, as it combines advanced medical knowledge with patient-centered care.

For those interested in the administrative side, a career as a certified professional coder is a strong option. This role involves translating medical data into codes crucial for billing and documentation.

Additionally, a bachelor of science in health information management salary can be an attractive consideration, as it prepares graduates for managing health data—an essential function in medical research and patient care environments linked to microbiology.

Best Scientists Citing Peter Halfmann

Trending Scientists